Serial #90071614
DEAD

Serial Number

90071614

Owner

NOVASIGNAL CORP.

Attorney

Laura Ganoza

Filing Date

Jul 24, 2020

Add to watchlist:

No watchlists yet
View on USPTO

Serial #90071614 Trademark

Serial Number: 90071614

Serial #90071614 is a trademark filed by NOVASIGNAL CORP. on July 24, 2020. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 36 (Insurance & Financial), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

NOVASIGNAL CORP. (13 trademarks)

2440 S. SEPULVEDA BLVD STE. 115
LOS ANGELES, CA 90064

Entity Type: 03

Trademark Details

Filing Date

July 24, 2020

Registration Date

Not Registered

Published for Opposition

December 29, 2020

Goods & Services

Educational services, namely, providing online and in-person instruction in the medical field for doctors, sonographers, and nurses; continuing education services, namely, providing in-person training and on-line and in-person continuing professional education lectures, seminars and classes in the medical field

Downloadable software using artificial intelligence in healthcare and medical field to assess medical conditions; computer hardware and recorded software, for use with medical patient monitoring equipment, for receiving, processing, transmitting and displaying data; downloadable computer software for providing an on-line database in the field of transaction processing to upload transactional data, provide statistical analysis, produce notifications and reports and integrate data from other software and medical devices; headsets for use with computers; downloadable mobile application for generation of reports, digital images and video clips in the medical and health care fields; downloadable mobile application for viewing medical and healthcare data files; downloadable application programming interface (API) software used to assess brain diseases, investigate efficacy of various drugs, and enable treatment of medical conditions

Extended warranty services, namely, service contracts; providing extended warranties on medical devices

Data analytics subscription management services delivered through digital platforms for physician and healthcare systems; compilation of statistics; compilation and systemization of information into computer databases; computerized file management; compilation of business data into computer databases

Medical services; medical ultrasound imaging services; medical services, namely, monitoring of patients; human healthcare services, namely, medical analysis of neurological conditions and other medical conditions for diagnostic and treatment purposes; telemedicine services; Analysis of medical data for diagnostic and treatment purposes; consulting services in the field of medical care and assessment of neurological conditions; maintaining patient medical records and files

Medical devices, namely, devices for measuring cerebral blood flow; medical apparatus and instruments for measuring cerebral blood flow and assessment of neurological conditions and other medical conditions; medical devices for assessment of neurological conditions; medical devices for enabling treatment of neurological conditions; medical devices for ultrasonography; medical devices, namely, transcranial doppler ultrasound devices; medical imaging devices for the brain; medical devices for automated assessment of medical conditions; medical ultrasound apparatus; diagnostic headsets for medical use for assessing medical conditions, for assessing neurological conditions, and for measuring cerebral blood flow; medical devices, namely, diagnostic headsets for assessing medical conditions, for assessing neurological conditions, and for measuring cerebral blood flow; kits for a transcranial doppler ultrasound scan comprised of medical ultrasound apparatus; medical robots with ultrasound apparatus for assessing neurological conditions, and for measuring cerebral blood flow

Development of computer software application solutions using artificial intelligence and machine learning; scientific computer programming services; development of systems for the processing of data; cloud computing and computer integration services featuring software for the assessing and enabling treatment of medical conditions; software as a service (SAAS) featuring software for the assessing and enabling treatment of medical conditions; cloud services in the nature of software as a service (SAAS) for the assessing and enabling treatment of medical conditions; application service provider featuring application programming interface (API) software for use by doctors and pharmacists on a database to assess brain diseases, investigate efficacy of various drugs, and enable treatment of medical conditions; scientific research, medical research; Compiling data for research purposes in the field of medical science and medical consultancy; analysis of medical data for medical research purposes

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Sep 25, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Sep 25, 2023 ABN6
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jul 26, 2023 ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jul 19, 2023 ASCK
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 23, 2023 EXRA
SOU EXTENSION 4 GRANTED
Feb 21, 2023 EX4G
SOU EXTENSION 4 FILED
Feb 21, 2023 EXT4
SOU TEAS EXTENSION RECEIVED
Feb 21, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 20, 2022 EXRA
SOU EXTENSION 3 GRANTED
Aug 18, 2022 EX3G
SOU EXTENSION 3 FILED
Aug 18, 2022 EXT3
SOU TEAS EXTENSION RECEIVED
Aug 18, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 22, 2022 EXRA
SOU EXTENSION 2 GRANTED
Feb 18, 2022 EX2G
SOU EXTENSION 2 FILED
Feb 18, 2022 EXT2
SOU TEAS EXTENSION RECEIVED
Feb 18, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 25, 2021 EXRA
SOU EXTENSION 1 GRANTED
Aug 23, 2021 EX1G
SOU EXTENSION 1 FILED
Aug 23, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Aug 23, 2021 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 23, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 29, 2020 NPUB
PUBLISHED FOR OPPOSITION
Dec 29, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 9, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 22, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 17, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 17, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 17, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 17, 2020 CNEA
ASSIGNED TO EXAMINER
Nov 10, 2020 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Aug 22, 2020 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 21, 2020 NWOS
NEW APPLICATION ENTERED
Jul 28, 2020 NWAP